Evidence map›Paper›PMID 33769736›Full record

ReviewIndian journal of dermatology, venereology and leprology

The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features.

Shyam B Verma, Saumya Panda, Pietro Nenoff, Archana Singal, Shivprakash M Rudramurthy, Silke Uhrlass, Anupam Das, Kavita Bisherwal, Dipika Shaw, Resham Vasani

Open access · diamondAbstract readReview
PubMed Publisher
In one paragraph

Review in Indian journal of dermatology, venereology and leprology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
17.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it, 159 citations in OpenAlex.

  1. Deep and disseminated dermatophytosis in immunocompromised populations-A systematic review.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Global Emergence ofInfection and drug resistance · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Epidemiological Trends and Clinical Features ofJournal of Korean medical science · 2025
    Article
  19. Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Shyam B VermaNirvan Skin Clinic, Vadodara, Gujarat, India.
Saumya PandaDepartment of Dermatology, Belle Vue Clinic, Kolkata, West Bengal, India.
Pietro NenoffDepartment of Dermatology and Laboratory Medicine, Laboratory of Medical Microbiology, Moelbis, Germany.
Archana SingalDepartment of Dermatology and STD, University College of Medical Sciences and GTB Hospital, Delhi, India.
Shivprakash M RudramurthyDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Silke UhrlassDepartment of Dermatology and Laboratory Medicine, Laboratory of Medical Microbiology, Moelbis, Germany.
Anupam DasDepartment of Dermatology, KPC Medical College and Hospital, Kolkata, West Bengal, India.
Kavita BisherwalDepartment of Dermatology, Venereology and Leprosy, Lady Hardinge Medical College and SSK Hospital, Delhi, India.
Dipika ShawDepartment of Medical Microbiology, PGI, Chandigarh, India.
Resham VasaniBhojani Clinic, Mumbai, Maharashtra, India.
Post Graduate Institute of Medical Education and Research · INLady Hardinge Medical College · INMedical College and Hospital, Kolkata · INUniversity College of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermatophytosis has attained unprecedented dimensions in recent years in India. Its clinical presentation is now multifarious, often with atypical morphology, severe forms and unusually extensive disease in all age groups. We hesitate to call it an epidemic owing to the lack of population-based prevalence surveys. In this part of the review, we discuss the epidemiology and clinical features of this contemporary problem. While the epidemiology is marked by a stark increase in the number of chronic, relapsing and recurrent cases, the clinical distribution is marked by a disproportionate rise in the number of cases with tinea corporis and cruris, cases presenting with the involvement of extensive areas, and tinea faciei.

Indexed as

Age DistributionDrug MisuseEducational StatusGlucocorticoidsHumansIatrogenic DiseaseIncidenceIndiaOccupationsPrevalenceQuality of LifeRecurrenceRisk FactorsRural PopulationSex DistributionSocial ClassGlucocorticoidsFixed-dose combination creamssuperficial dermatophytosistineatopical steroids

Identifiers

PMID33769736
OpenAlexW3136423285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.